Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

AbbVie Inc. (ABBV) News - StockMarketCap

Stocks›AbbVie Inc.☆

● At closeAs of Jul 2, 2026

AbbVie Inc.

ABBV✓

HealthcareDrug Manufacturers - GeneralNYSE

$261.07+3.99%

$461.26BMarket cap

123.28xP/E ratio

4.96MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$261.07

$10.01 (+3.99%) · 24h

Key metrics

Market cap$461.26B+18.18%

Enterprise value$507.67B

Volume (24h)4.96M

P/E ratio (TTM)123.28x

P/S ratio (TTM)7.07x

Dividend yield2.68%

Shares outstanding1.77B

Trading range

Previous close$251.06

Day range$250.51 - $261.64

52-week range$184.39 - $255.99

AbbVie Inc. (ABBV) operates in the Drug Manufacturers - General industry within the Healthcare sector, listed on NYSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Novartis AG+2.42%

Latest news